These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7611707)

  • 1. Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia.
    Meldrum BS
    Ann N Y Acad Sci; 1995 May; 757():492-505. PubMed ID: 7611707
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of excitatory amino acids in brain injury caused by hypoxia-ischemia, status epilepticus, and hypoglycemia.
    Clark GD
    Clin Perinatol; 1989 Jun; 16(2):459-74. PubMed ID: 2545404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearranging receptors.
    Brooks-Kayal AR
    Epilepsia; 2005; 46 Suppl 7():29-38. PubMed ID: 16201993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.
    Meldrum B
    Clin Sci (Lond); 1985 Feb; 68(2):113-22. PubMed ID: 2857118
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties.
    Bullock R; Kuroda Y; Teasdale GM; McCulloch J
    Acta Neurochir Suppl (Wien); 1992; 55():49-55. PubMed ID: 1357922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disorders: clues from glutamate and energy metabolism.
    Ikonomidou C; Turski L
    Crit Rev Neurobiol; 1996; 10(2):239-63. PubMed ID: 8971131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent desensitization to glutamate: possible role in epilepsy.
    Fisher RS; Cole AE
    Epilepsy Res Suppl; 1992; 8():197-201. PubMed ID: 1358098
    [No Abstract]   [Full Text] [Related]  

  • 8. Maturational aspects of epilepsy mechanisms and consequences for the immature brain.
    Sanchez RM; Jensen FE
    Epilepsia; 2001 May; 42(5):577-85. PubMed ID: 11380563
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonizing excitotoxicity: a therapeutic strategy for stroke?
    Choi D
    Mt Sinai J Med; 1998 Mar; 65(2):133-8. PubMed ID: 9520517
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of excitotoxins in developmental neuropathology.
    Olney JW
    APMIS Suppl; 1993; 40():103-12. PubMed ID: 8311990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuronal degeneration and glutamate].
    Kirino T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1522-5. PubMed ID: 2576528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid receptors and antiepileptic drug development.
    Meldrum BS; Chapman AG
    Adv Neurol; 1999; 79():965-78. PubMed ID: 10514879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacology of excitatory amino acid receptors].
    Shinozaki H
    Yakubutsu Seishin Kodo; 1992 Apr; 12(2):55-65. PubMed ID: 1359719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke: "acidotoxicity" is a perpetrator.
    Huang Y; McNamara JO
    Cell; 2004 Sep; 118(6):665-6. PubMed ID: 15369664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of nitric oxide in brain glutaminergic pathology].
    Raevskiĭ KS; Bashkatova VG; Vanin AF
    Vestn Ross Akad Med Nauk; 2000; (4):11-5. PubMed ID: 10832407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in glutamate receptors after brain ischemia].
    Kawai N; Tsubokawa H; Oguro K
    Tanpakushitsu Kakusan Koso; 2000 Feb; 45(3 Suppl):507-14. PubMed ID: 10707664
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of epileptiform discharges in neocortical neurons following glutamate uptake inhibition.
    Campbell S; Hablitz JJ
    Epilepsia; 2005; 46 Suppl 5():129-33. PubMed ID: 15987267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is glutamate a trigger factor in epileptic hyperactivity?
    Coutinho-Netto J; Abdul-Ghani AS; Collins JF; Bradford HF
    Epilepsia; 1981 Jun; 22(3):289-96. PubMed ID: 7238433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New in vitro model of traumatic neuronal injury: evaluation of secondary injury and glutamate receptor-mediated neurotoxicity.
    Mukhin AG; Ivanova SA; Knoblach SM; Faden AI
    J Neurotrauma; 1997 Sep; 14(9):651-63. PubMed ID: 9337127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GluR2 hypothesis: Ca(++)-permeable AMPA receptors in delayed neurodegeneration.
    Bennett MV; Pellegrini-Giampietro DE; Gorter JA; Aronica E; Connor JA; Zukin RS
    Cold Spring Harb Symp Quant Biol; 1996; 61():373-84. PubMed ID: 9246466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.